A team of scientists from across Europe are embarking on new research to develop a treatment for food allergy.
"Food allergy affects around 10 million EU citizens and there is no cure," says Dr Clare Mills of the Institute of Food Research, a lead partner in the Food Allergy Specific Therapy (FAST) research project. "All people with food allergy can do is avoid the foods to which they are allergic. The threat of severe anaphylaxis has a great impact on their quality of life."
Attempted treatment with allergen-specific immunotherapy, where a patient received monthly injections with an allergen extract for three to five years, failed because it could cause anaphylaxis as a side effect.
Anaphylaxis is a severe allergic reaction involving the whole body, often within minutes of exposure to the allergen. Peanut allergy is the most widely known cause, but other causes of anaphylaxis include other foods, insect stings, latex and drugs. If untreated in time it can be fatal.
In the FAST project, scientists will use modified variants of allergic proteins that are hypoallergenic and therefore safer. The proteins will be purified making them more effective and making it easier to control the dose.
Ninety percent of all food allergies are caused by about 10 foods. Allergies to fish and fruit are among the most common in Europe. In fish allergy the protein responsible is parvalbumin and in fruit it is lipid transfer protein (LTP). Modified hypo-allergenic versions of these proteins will be produced at tested as potential treatments.
"We are hoping for a cure that will allow people to eat fish or fruit again," says Dr Ronald van Ree from the Academic Medical Center at the University of Amsterdam. "But a significant reduction of sensitivity would already be a great step forwards.
"The risk of unintentional exposure due to cross-contamination of foods, or while eating in restaurants or at parties, will decrease. This will take away lot of the anxiety that has a negative impact on the quality of life of food allergy sufferers."
IFR Press Office
Zoe Dunford, Tel: 01603 255111, email: firstname.lastname@example.org
Andrew Chapple, Tel: 01603 251490, email: email@example.com
Notes to editors
For online information on the project: http://www.allergome.org:8080/fast/index.jsp
The mission of the Institute of Food Research (www.ifr.ac.uk) is to undertake international quality scientific research relevant to food and human health and to work in partnership with others to provide underpinning science for consumers, policy makers, the food industry and academia. It is a company limited by guarantee, with charitable status, grant aided by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk).
The Academic Medical Center (AMC) is one of the foremost research institutions of the Netherlands as well as one of the largest hospitals. The AMC complex houses the university hospital and the medical faculty of the University of Amsterdam, as well the Netherlands Institute Neurosciences and, the medical department of the Royal Tropical Institute. In the coming years, a national Neuroimaging Center will arise next to the AMC. Also a number of biotech companies – partly AMC spin-offs - are located on the premises. This concentration of expertise makes the AMC a breeding ground for fruitful scientific collaboration. The AMC houses all medical specializations that are recognized in the Netherlands, and all types of top clinical patient care.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.